共 225 条
[1]
Argeudas MR(2003)Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Am J Gastroenterol 98 679-690
[2]
Chen VK(2012)Is hepatitis C virus carcinogenic? Gastroenterology 142 1274-1278
[3]
Eloubeidi MA(1996)Poynard T and the French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C Hepatology. 24 289-293
[4]
Fallon MB(2003)Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population J Am Med Assoc 290 228-237
[5]
Lemon SM(2008)Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression Hepatology 48 418-431
[6]
McGiven DR(1997)Estimates of the cost effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C Ann Intern Med 127 855-865
[7]
Bedossa P(2001)Estimating progression to cirrhosis in chronic hepatitis C virus infection Hepatology 34 809-816
[8]
Salomon JA(2009)Cost-effectiveness of pegylated interferon and ribivarin for patients with chronic hepatitis C treated in routine clinical practice Int J Technol Assess Health Care. 25 171-180
[9]
Weinstein MC(2011)Structural frameworks and key model parameters in cost-effectiveness analyses for current and future treatments of chronic hepatitis C Value Health 14 1068-1077
[10]
Hammitt JK(1997)Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463-472